{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:47:46Z","timestamp":1794019666558,"version":"4.8.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13346-025-01904-x","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T12:59:19Z","timestamp":1751720359000},"page":"3286-3309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Zonisamide nanodiamonds for brain targeting: A comprehensive study utilising in silico, in vitro, in vivo, and molecular investigation for successful nose-to-brain delivery for epilepsy management"],"prefix":"10.1007","volume":"16","author":[{"given":"Nihal Mohamed Elmahdy","family":"Elsayyad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar A.","family":"Elkady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Swidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan M.","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr M.","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai A.","family":"Zaafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4938-2532","authenticated-orcid":false,"given":"Hanan M.","family":"El-Laithy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"1904_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jconrel.2015.12.041","volume":"240","author":"L Crawford","year":"2016","unstructured":"Crawford L, Rosch J, Putnam D. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system. J Control Release. 2016;240:251\u201366. https:\/\/doi.org\/10.1016\/j.jconrel.2015.12.041.","journal-title":"J Control Release"},{"key":"1904_CR2","doi-asserted-by":"publisher","first-page":"114485","DOI":"10.1016\/j.addr.2022.114485","volume":"189","author":"AC Correia","year":"2022","unstructured":"Correia AC, Monteiro AR, Silva R, Moreira JN, Sousa Lobo JM, Silva AC. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders. Adv Drug Deliv Rev. 2022;189:114485. https:\/\/doi.org\/10.1016\/j.addr.2022.114485.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"1904_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1080\/14656566.2019.1595584","volume":"20","author":"A Reimers","year":"2019","unstructured":"Reimers A, Ljung H. An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy. Expert Opin Pharmacother. 2019;20(8):909\u201315. https:\/\/doi.org\/10.1080\/14656566.2019.1595584.","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"1904_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1365-2885.2008.00993.x","volume":"31","author":"DM Boothe","year":"2008","unstructured":"Boothe DM, Perkins J. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs. J Vet Pharmacol Ther. 2008;31(6):544\u201353. https:\/\/doi.org\/10.1111\/j.1365-2885.2008.00993.x.","journal-title":"J Vet Pharmacol Ther"},{"key":"1904_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0169-409X(98)00082-9","volume":"36","author":"E Cornford","year":"1999","unstructured":"Cornford E, Hyman S. Blood-brain barrier permeability to small and large molecules. Adv Drug Deliv Rev. 1999;36:145\u201363.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1904_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ejps.2010.05.003","volume":"40","author":"MI Alam","year":"2010","unstructured":"Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, et al. Strategy for effective brain drug delivery. Eur J Pharm Sci. 2010;40(5):385\u2013403. https:\/\/doi.org\/10.1016\/j.ejps.2010.05.003.","journal-title":"Eur J Pharm Sci"},{"key":"1904_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jddst.2017.09.021","volume":"43","author":"DMN Abouhussein","year":"2018","unstructured":"Abouhussein DMN, Khattab A, Bayoumi NA, Mahmoud AF, Sakr TM. Brain targeted rivastigmine mucoadhesive thermosensitive in situ gel: Optimization, in vitro evaluation, radiolabeling, in vivo pharmacokinetics and biodistribution. J Drug Deliv Sci Technol. 2018;43:129\u201340. https:\/\/doi.org\/10.1016\/j.jddst.2017.09.021.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"7","key":"1904_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/17425247.2013.790887","volume":"10","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi CV, Belgamwar VS. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv. 2013;10(7):957\u201372.","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"1904_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11095-020-02786-z","volume":"37","author":"J Goncalves","year":"2020","unstructured":"Goncalves J, Alves G, Carona A, Bicker J, Vitorino C, Falcao A, et al. Pre-clinical assessment of the nose-to-brain delivery of zonisamide after intranasal administration. Pharm Res. 2020;37(4):74. https:\/\/doi.org\/10.1007\/s11095-020-02786-z.","journal-title":"Pharm Res"},{"key":"1904_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","volume":"268","author":"AR Khan","year":"2017","unstructured":"Khan AR, Liu M, Khan MW, Zhai G. Progress in brain targeting drug delivery system by nasal route. J Control Release. 2017;268:364\u201389. https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.001.","journal-title":"J Control Release"},{"issue":"2","key":"1904_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.drudis.2018.10.012","volume":"24","author":"J Saraf","year":"2019","unstructured":"Saraf J, Kalia K, Bhattacharya P, Tekade RK. Growing synergy of nanodiamonds in neurodegenerative interventions. Drug Discov Today. 2019;24(2):584\u201394. https:\/\/doi.org\/10.1016\/j.drudis.2018.10.012.","journal-title":"Drug Discov Today"},{"issue":"1","key":"1904_CR12","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/s41598-017-16703-9","volume":"8","author":"U Roy","year":"2018","unstructured":"Roy U, Drozd V, Durygin A, Rodriguez J, Barber P, Atluri V, et al. Characterization of nanodiamond-based anti-HIV drug delivery to the brain. Sci Rep. 2018;8(1):1603. https:\/\/doi.org\/10.1038\/s41598-017-16703-9.","journal-title":"Sci Rep"},{"key":"1904_CR13","doi-asserted-by":"publisher","first-page":"1259648","DOI":"10.3389\/fnano.2023.1259648","volume":"5","author":"D Singh","year":"2023","unstructured":"Singh D, Ray S. A short appraisal of nanodiamonds in drug delivery and targeting: recent advancements. Front Nanotechnol. 2023;5:1259648. https:\/\/doi.org\/10.3389\/fnano.2023.1259648.","journal-title":"Front Nanotechnol"},{"issue":"2","key":"1904_CR14","doi-asserted-by":"publisher","first-page":"2100109","DOI":"10.1002\/anbr.202100109","volume":"2","author":"L Xu","year":"2022","unstructured":"Xu L, Wang X, Liu Y, Yang G, Falconer RJ, Zhao CX. Lipid nanoparticles for drug delivery. Adv NanoBiomed Res. 2022;2(2):2100109. https:\/\/doi.org\/10.1002\/anbr.202100109.","journal-title":"Adv NanoBiomed Res"},{"key":"1904_CR15","doi-asserted-by":"publisher","first-page":"1024143","DOI":"10.3389\/fbioe.2022.1024143","volume":"10","author":"X Xiao","year":"2022","unstructured":"Xiao X, Teng F, Shi C, Chen J, Wu S, Wang B, et al. Polymeric nanoparticles\u2014promising carriers for cancer therapy. Front Bioeng Biotechnol. 2022;10:1024143. https:\/\/doi.org\/10.3389\/fbioe.2022.1024143.","journal-title":"Front Bioeng Biotechnol"},{"key":"1904_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fphar.2019.00220","volume":"10","author":"NM La-Beck","year":"2019","unstructured":"La-Beck NM, Liu X, Wood LM. Harnessing liposome interactions with the immune system for the next breakthrough in cancer drug delivery. Front Pharmacol. 2019;10:220. https:\/\/doi.org\/10.3389\/fphar.2019.00220.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1904_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/pharmaceutics2020182","volume":"2","author":"F Chaibva","year":"2010","unstructured":"Chaibva F, Burton M, Walker RB. Optimization of salbutamol sulfate dissolution from sustained release matrix formulations using an artificial neural network. Pharmaceutics. 2010;2(2):182\u201398. https:\/\/doi.org\/10.3390\/pharmaceutics2020182.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1904_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.apsb.2018.09.010","volume":"9","author":"Y Yang","year":"2019","unstructured":"Yang Y, Ye Z, Su Y, Zhao Q, Li X, Ouyang D. Deep learning for in vitro prediction of pharmaceutical formulations. Acta Pharm Sin B. 2019;9(1):177\u201385. https:\/\/doi.org\/10.1016\/j.apsb.2018.09.010.","journal-title":"Acta Pharm Sin B"},{"key":"1904_CR19","doi-asserted-by":"publisher","first-page":"107590","DOI":"10.1016\/j.diamond.2019.107590","volume":"100","author":"J Beltz","year":"2019","unstructured":"Beltz J, Pfaff A, Abdullahi IM, Cristea A, Mochalin VN, Ercal N. Effect of nanodiamond surface chemistry on adsorption and release of tiopronin. Diamond Relat Mater. 2019;100:107590. https:\/\/doi.org\/10.1016\/j.diamond.2019.107590.","journal-title":"Diamond Relat Mater"},{"issue":"8","key":"1904_CR20","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1021\/mp5001108","volume":"11","author":"TB Toh","year":"2014","unstructured":"Toh TB, Lee DK, Hou W, Abdullah LN, Nguyen J, Ho D, et al. Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells. Mol Pharm. 2014;11(8):2683\u201391. https:\/\/doi.org\/10.1021\/mp5001108.","journal-title":"Mol Pharm"},{"issue":"1","key":"1904_CR21","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1080\/21691401.2019.1677681","volume":"47","author":"K Locharoenrat","year":"2019","unstructured":"Locharoenrat K. Efficacy of nanodiamond-doxorubicin complexes on human breast adenocarcinoma cell lines. Artif Cells Nanomed Biotechnol. 2019;47(1):4053\u20138. https:\/\/doi.org\/10.1080\/21691401.2019.1677681.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"5","key":"1904_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1208\/s12249-020-01721-0","volume":"21","author":"D Liu","year":"2020","unstructured":"Liu D, Qiao S, Cheng B, Li D, Chen J, Wu Q, et al. Enhanced oral delivery of curcumin via vitamin E TPGS modified nanodiamonds: A comparative study on the efficacy of non-covalent and covalent conjugated strategies. AAPS PharmSciTech. 2020;21(5):187. https:\/\/doi.org\/10.1208\/s12249-020-01721-0.","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"1904_CR23","doi-asserted-by":"publisher","first-page":"11490","DOI":"10.1021\/acsnano.5b05718","volume":"9","author":"D-K Lee","year":"2015","unstructured":"Lee D-K, Kim SV, Limansubroto AN, Yen A, Soundia A, Wang C-Y, et al. Nanodiamond\u2013gutta percha composite biomaterials for root canal therapy. ACS Nano. 2015;9(11):11490\u2013501. https:\/\/doi.org\/10.1021\/acsnano.5b05718.","journal-title":"ACS Nano"},{"key":"1904_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.msec.2016.02.075","volume":"63","author":"P Rouhani","year":"2016","unstructured":"Rouhani P, Govindaraju N, Iyer JK, Kaul R, Kaul A, Singh RN. Purification and functionalization of nanodiamond to serve as a platform for amoxicillin delivery. Mater Sci Eng C Mater Biol Appl. 2016;63:323\u201332. https:\/\/doi.org\/10.1016\/j.msec.2016.02.075.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"7","key":"1904_CR25","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1166\/jnn.2020.17896","volume":"20","author":"P Rouhani","year":"2020","unstructured":"Rouhani P, Singh RN. Polyethyleneimine-functionalized magnetic Fe\u2083O\u2084 and nanodiamond particles as a platform for amoxicillin delivery. J Nanosci Nanotechnol. 2020;20(7):3957\u201370. https:\/\/doi.org\/10.1166\/jnn.2020.17896.","journal-title":"J Nanosci Nanotechnol"},{"key":"1904_CR26","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.2147\/IJN.S104859","volume":"11","author":"DG Lim","year":"2016","unstructured":"Lim DG, Kim KH, Kang E, Lim SH, Ricci J, Sung SK, et al. Comprehensive evaluation of carboxylated nanodiamond as a topical drug delivery system. Int J Nanomed. 2016;11:2381\u201395. https:\/\/doi.org\/10.2147\/IJN.S104859.","journal-title":"Int J Nanomed"},{"issue":"20","key":"1904_CR27","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1016\/j.biomaterials.2014.03.041","volume":"35","author":"L Zhao","year":"2014","unstructured":"Zhao L, Xu YH, Akasaka T, Abe S, Komatsu N, Watari F, et al. Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells. Biomaterials. 2014;35(20):5393\u2013406. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.03.041.","journal-title":"Biomaterials"},{"key":"1904_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/NSA.S232517","volume":"12","author":"SH Alawdi","year":"2019","unstructured":"Alawdi SH, Eidi H, Safar MM, Abdel-Wahhab MA. Loading amlodipine on diamond nanoparticles: A novel drug delivery system. Nanotechnol Sci Appl. 2019;12:47\u201353. https:\/\/doi.org\/10.2147\/NSA.S232517.","journal-title":"Nanotechnol Sci Appl"},{"key":"1904_CR29","doi-asserted-by":"publisher","first-page":"110413","DOI":"10.1016\/j.msec.2019.110413","volume":"108","author":"W Long","year":"2020","unstructured":"Long W, Ouyang H, Wan W, Yan W, Zhou C, Huang H, et al. \u201cTwo in one\u201d: Simultaneous functionalization and DOX loading for fabrication of nanodiamond-based pH responsive drug delivery system. Mater Sci Eng C Mater Biol Appl. 2020;108:110413. https:\/\/doi.org\/10.1016\/j.msec.2019.110413.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"19","key":"1904_CR30","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1039\/c7tb00449d","volume":"5","author":"H Zhu","year":"2017","unstructured":"Zhu H, Wang Y, Hussain A, Zhang Z, Shen Y, Guo S. Nanodiamond-mediated co-delivery of doxorubicin and malaridine to maximize synergistic anti-tumor effects on multi-drug resistant MCF-7\/ADR cells. J Mater Chem B. 2017;5(19):3531\u201340. https:\/\/doi.org\/10.1039\/c7tb00449d.","journal-title":"J Mater Chem B"},{"key":"1904_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.diamond.2018.06.024","volume":"88","author":"P Wang","year":"2018","unstructured":"Wang P, Su W, Ding X. Control of nanodiamond-doxorubicin drug loading and elution through optimized compositions and release environments. Diam Relat Mater. 2018;88:43\u201350. https:\/\/doi.org\/10.1016\/j.diamond.2018.06.024.","journal-title":"Diam Relat Mater"},{"issue":"1","key":"1904_CR32","doi-asserted-by":"publisher","first-page":"19517","DOI":"10.1038\/s41598-020-76477-5","volume":"10","author":"SA Damiati","year":"2020","unstructured":"Damiati SA, Rossi D, Joensson HN, Damiati S. Artificial intelligence application for rapid fabrication of size-tunable PLGA microparticles in microfluidics. Sci Rep. 2020;10(1):19517. https:\/\/doi.org\/10.1038\/s41598-020-76477-5.","journal-title":"Sci Rep"},{"issue":"1","key":"1904_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40204-022-00179-6","volume":"11","author":"IM Cardoso-Daodu","year":"2022","unstructured":"Cardoso-Daodu IM, Ilomuanya MO, Amenaghawon AN, Azubuike CP. Artificial neural network for optimizing the formulation of curcumin-loaded liposomes from statistically designed experiments. Prog Biomater. 2022;11(1):55\u201365. https:\/\/doi.org\/10.1007\/s40204-022-00179-6.","journal-title":"Prog Biomater"},{"key":"1904_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ejpb.2017.06.030","volume":"119","author":"J Youshia","year":"2017","unstructured":"Youshia J, Ali ME, Lamprecht A. Artificial neural network based particle size prediction of polymeric nanoparticles. Eur J Pharm Biopharm. 2017;119:333\u201342. https:\/\/doi.org\/10.1016\/j.ejpb.2017.06.030.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1904_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1208\/s12249-019-1561-2","volume":"21","author":"OA Elkady","year":"2019","unstructured":"Elkady OA, Tadros MI, El-Laithy HM. QbD approach for novel crosslinker-free ionotropic gelation of risedronate sodium-chitosan nebulizable microspheres: Optimization and characterization. AAPS PharmSciTech. 2019;21(1):14. https:\/\/doi.org\/10.1208\/s12249-019-1561-2.","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"1904_CR36","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1021\/mp400213z","volume":"10","author":"VN Mochalin","year":"2013","unstructured":"Mochalin VN, Pentecost A, Li X-M, Neitzel I, Nelson M, Wei C, et al. Adsorption of drugs on nanodiamond: Towards development of a drug delivery platform. Mol Pharm. 2013;10(10):3728\u201335. https:\/\/doi.org\/10.1021\/mp400213z.","journal-title":"Mol Pharm"},{"issue":"2","key":"1904_CR37","doi-asserted-by":"publisher","first-page":"502","DOI":"10.52711\/0974-360x.2022.00081","volume":"15","author":"SH Noshi","year":"2022","unstructured":"Noshi SH, Basha M, Awad GE, Elsayyad NME. Miconazole nitrate loaded Soluplus\u00ae-Pluronic\u00ae nano-micelles as promising drug delivery systems for ocular fungal infections: in vitro and in vivo considerations. Res J Pharm Technol. 2022;15(2):502\u201311. https:\/\/doi.org\/10.52711\/0974-360x.2022.00081.","journal-title":"Res J Pharm Technol"},{"key":"1904_CR38","doi-asserted-by":"publisher","first-page":"121001","DOI":"10.1016\/j.lfs.2022.121001","volume":"309","author":"NME Elsayyad","year":"2022","unstructured":"Elsayyad NME, Gomaa I, Salem MA, Amer R, El-Laithy HM. Efficient lung-targeted delivery of risedronate sodium\/vitamin D3 conjugated PAMAM-G5 dendrimers for managing osteoporosis: Pharmacodynamics, molecular pathways, and metabolomics considerations. Life Sci. 2022;309:121001. https:\/\/doi.org\/10.1016\/j.lfs.2022.121001.","journal-title":"Life Sci"},{"key":"1904_CR39","doi-asserted-by":"publisher","first-page":"106710","DOI":"10.1016\/j.jddst.2025.106710","volume":"107","author":"NME Elsayyad","year":"2025","unstructured":"Elsayyad NME, Ibrahim MS, Noshi SH. Sustainable pH-responsive casein\/hyaluronic acid layered nanoparticles for targeted delivery of metformin to colorectal cancer. J Drug Deliv Sci Technol. 2025;107:106710. https:\/\/doi.org\/10.1016\/j.jddst.2025.106710.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"1904_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.17586\/2220-8054-2018-9-3-370-377","volume":"9","author":"AN Bokarev","year":"2018","unstructured":"Bokarev AN, Plastun IL. Possibility of drug delivery due to hydrogen bonds formation in nanodiamonds and doxorubicin: molecular modeling. Nanosyst Phys Chem Math. 2018;9(3):370\u20137.","journal-title":"Nanosyst Phys Chem Math"},{"key":"1904_CR41","doi-asserted-by":"publisher","first-page":"101788","DOI":"10.1016\/j.jddst.2020.101788","volume":"58","author":"NME Elsayyad","year":"2020","unstructured":"Elsayyad NME, Salama A, Noshi SH. Concurrent tissue engineering and infection prophylaxis utilizing stable dual-action amoxicillin-loaded scaffolds. J Drug Deliv Sci Technol. 2020;58:101788. https:\/\/doi.org\/10.1016\/j.jddst.2020.101788.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"1904_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3109\/1061186X.2013.776054","volume":"21","author":"AA Badawi","year":"2013","unstructured":"Badawi AA, El-Laithy HM, Nesseem DI, El-Husseney SS. Pharmaceutical and medical aspects of hyaluronic acid-ketorolac combination therapy in osteoarthritis treatment: Radiographic imaging and bone mineral density. J Drug Target. 2013;21(6):551\u201363. https:\/\/doi.org\/10.3109\/1061186X.2013.776054.","journal-title":"J Drug Target"},{"issue":"5","key":"1904_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.22159\/ijap.2021v13i5.42216","volume":"13","author":"MS Ibrahim","year":"2021","unstructured":"Ibrahim MS, ElmahdyElsayyad NM, Salama ABEER, Noshi SH. Quality by design (QbD) as a tool for the optimization of indomethacin freeze-dried sublingual tablets: In vitro and in vivo evaluation. Int J App Pharm. 2021;13(5):160\u201371. https:\/\/doi.org\/10.22159\/ijap.2021v13i5.42216.","journal-title":"Int J App Pharm"},{"issue":"1","key":"1904_CR44","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1080\/10717544.2021.1905747","volume":"28","author":"HM El-Laithy","year":"2021","unstructured":"El-Laithy HM, Youssef A, El-Husseney SS, El Sayed NS, Maher A. Enhanced alveo-pulmonary deposition of nebulized ciclesonide for attenuating airways inflammations: A strategy to overcome metered-dose inhaler drawbacks. Drug Deliv. 2021;28(1):826\u201343. https:\/\/doi.org\/10.1080\/10717544.2021.1905747.","journal-title":"Drug Deliv"},{"issue":"6","key":"1904_CR45","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/10837450.2020.1740257","volume":"25","author":"S Arisoy","year":"2020","unstructured":"Arisoy S, Sayiner O, Comoglu T, Onal D, Atalay O, Pehlivanoglu B. In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose-to-brain delivery. Pharm Dev Technol. 2020;25(6):735\u201347. https:\/\/doi.org\/10.1080\/10837450.2020.1740257.","journal-title":"Pharm Dev Technol"},{"key":"1904_CR46","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.2147\/DDDT.S102500","volume":"11","author":"AM Fatouh","year":"2017","unstructured":"Fatouh AM, Elshafeey AH, Abdelbary A. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: Formulation, optimization, and in vivo pharmacokinetics. Drug Des Devel Ther. 2017;11:1815\u201325. https:\/\/doi.org\/10.2147\/DDDT.S102500.","journal-title":"Drug Des Devel Ther"},{"key":"1904_CR47","doi-asserted-by":"publisher","first-page":"119514","DOI":"10.1016\/j.ijpharm.2020.119514","volume":"586","author":"WI El-Ghareb","year":"2020","unstructured":"El-Ghareb WI, Swidan MM, Ibrahim IT, Abd El-Bary A, Tadros MI, Sakr TM. (99m)Tc-doxorubicin-loaded gallic acid-gold nanoparticles ((99m)Tc-DOX-loaded GA-Au NPs) as a multifunctional theranostic agent. Int J Pharm. 2020;586:119514. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119514.","journal-title":"Int J Pharm"},{"issue":"9","key":"1904_CR48","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s13346-024-01528-7","volume":"14","author":"MM Ibrahim","year":"2024","unstructured":"Ibrahim MM, Basalious EB, El-Nabarawi MA, Makhlouf AIA, Sayyed ME, Ibrahim IT. Nose-to-brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution, and pharmacokinetic study. Drug Deliv Transl Res. 2024;14(9):2539\u201357. https:\/\/doi.org\/10.1007\/s13346-024-01528-7.","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"1904_CR49","doi-asserted-by":"publisher","first-page":"e3533","DOI":"10.21769\/BioProtoc.3533","volume":"10","author":"MN Arshad","year":"2020","unstructured":"Arshad MN, Naegele JR. Induction of temporal lobe epilepsy in mice with pilocarpine. Bio-Protoc. 2020;10(4):e3533. https:\/\/doi.org\/10.21769\/BioProtoc.3533.","journal-title":"Bio-Protoc"},{"issue":"5","key":"1904_CR50","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/epi.13348","volume":"57","author":"D Wang","year":"2016","unstructured":"Wang D, Li Z, Zhang Y, Wang G, Wei M, Hu Y, et al. Targeting of microRNA-199a-5p protects against pilocarpine-induced status epilepticus and seizure damage via the SIRT1-p53 cascade. Epilepsia. 2016;57(5):706\u201316. https:\/\/doi.org\/10.1111\/epi.13348.","journal-title":"Epilepsia"},{"key":"1904_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.omtm.2018.03.001","volume":"9","author":"C Falcicchia","year":"2018","unstructured":"Falcicchia C, Paolone G, Emerich DF, Lovisari F, Bell WJ, Fradet T, et al. Seizure-suppressant and neuroprotective effects of encapsulated BDNF-producing cells in a rat model of temporal lobe epilepsy. Mol Ther Methods Clin Dev. 2018;9:211\u201324. https:\/\/doi.org\/10.1016\/j.omtm.2018.03.001.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"12","key":"1904_CR52","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10822-011-9478-1","volume":"25","author":"M Muehlbacher","year":"2011","unstructured":"Muehlbacher M, Spitzer GM, Liedl KR, Kornhuber J. Qualitative prediction of blood-brain barrier permeability on a large and refined dataset. J Comput Aided Mol Des. 2011;25(12):1095\u2013106. https:\/\/doi.org\/10.1007\/s10822-011-9478-1.","journal-title":"J Comput Aided Mol Des"},{"key":"1904_CR53","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fphar.2018.00451","volume":"9","author":"H Song","year":"2018","unstructured":"Song H, Tufa U, Chow J, Sivanenthiran N, Cheng C, Lim S, et al. Effects of anti-epileptic drugs on spontaneous recurrent seizures in a novel model of extended hippocampal kindling in mice. Front Pharmacol. 2018;9:451. https:\/\/doi.org\/10.3389\/fphar.2018.00451.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1904_CR54","doi-asserted-by":"publisher","first-page":"837","DOI":"10.26355\/eurrev_202101_24648","volume":"25","author":"MA Zaafan","year":"2021","unstructured":"Zaafan MA, Abdelhamid AM. The cardioprotective effect of microRNA-103 inhibitor against isoprenaline-induced myocardial infarction in mice through targeting the FADD\/RIPK pathway. Eur Rev Med Pharmacol Sci. 2021;25(2):837\u201344. https:\/\/doi.org\/10.26355\/eurrev_202101_24648.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"1904_CR55","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1007\/s00213-022-06262-x","volume":"239","author":"OA Ahmedy","year":"2022","unstructured":"Ahmedy OA, Abdelghany TM, El-Shamarka MEA, Khattab MA, El-Tanbouly DM. Apigenin attenuates LPS-induced neurotoxicity and cognitive impairment in mice via promoting mitochondrial fusion\/mitophagy: Role of the SIRT3\/PINK1\/Parkin pathway. Psychopharmacology. 2022;239(12):3903\u201317. https:\/\/doi.org\/10.1007\/s00213-022-06262-x.","journal-title":"Psychopharmacology"},{"issue":"1","key":"1904_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/pharmaceutics14010183","volume":"14","author":"S Wang","year":"2022","unstructured":"Wang S, Di J, Wang D, Dai X, Hua Y, Gao X, et al. State-of-the-art review of artificial neural networks to predict, characterize, and optimize pharmaceutical formulation. Pharmaceutics. 2022;14(1):183. https:\/\/doi.org\/10.3390\/pharmaceutics14010183.","journal-title":"Pharmaceutics."},{"issue":"8","key":"1904_CR57","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/10837450.2023.2251574","volume":"28","author":"SH Noshi","year":"2023","unstructured":"Noshi SH, Ibrahim MS, Salama A, Fathy IA, Elsayyad NME. Chondroitin sulphate-chitosan polyelectrolyte complexes for etoricoxib transdermal delivery: In silico, in vitro, and in vivo studies. Pharm Dev Technol. 2023;28(8):785\u201398. https:\/\/doi.org\/10.1080\/10837450.2023.2251574.","journal-title":"Pharm Dev Technol"},{"issue":"11","key":"1904_CR58","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1002\/jbm.a.36175","volume":"105","author":"RM Hathout","year":"2017","unstructured":"Hathout RM, Gad HA, Metwally AA. Gelatinized-core liposomes: Toward a more robust carrier for hydrophilic molecules. J Biomed Mater Res A. 2017;105(11):3086\u201392. https:\/\/doi.org\/10.1002\/jbm.a.36175.","journal-title":"J Biomed Mater Res A"},{"key":"1904_CR59","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejpb.2015.04.028","volume":"94","author":"Y Li","year":"2015","unstructured":"Li Y, Abbaspour MR, Grootendorst PV, Rauth AM, Wu XY. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology. Eur J Pharm Biopharm. 2015;94:170\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2015.04.028.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1904_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ultsonch.2009.04.007","volume":"17","author":"NL Ngoc","year":"2010","unstructured":"Ngoc NL, Takaomi K. Ultrasound stimulus effect on hydrogen bonding in networked alumina and polyacrylic acid slurry. Ultrason Sonochem. 2010;17(1):186\u201392. https:\/\/doi.org\/10.1016\/j.ultsonch.2009.04.007.","journal-title":"Ultrason Sonochem"},{"issue":"9","key":"1904_CR61","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1080\/03639045.2023.2259993","volume":"49","author":"MS Ibrahim","year":"2023","unstructured":"Ibrahim MS, Elsayyad NME, Salama A, Noshi SH. Utilization of response surface design for development and optimization of rosuvastatin calcium-loaded nano-squarticles for hair growth stimulating VEGF and IGF production: In-vitro and in-vivo evaluation. Drug Dev Ind Pharm. 2023;49(9):580\u20139. https:\/\/doi.org\/10.1080\/03639045.2023.2259993.","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"1904_CR62","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.drudis.2018.01.005","volume":"23","author":"Y Feng","year":"2018","unstructured":"Feng Y, He H, Li F, Lu Y, Qi J, Wu W. An update on the role of nanovehicles in nose-to-brain drug delivery. Drug Discov Today. 2018;23(5):1079\u201388. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.005.","journal-title":"Drug Discov Today"},{"issue":"3","key":"1904_CR63","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1039\/c3em00378g","volume":"16","author":"C Desai","year":"2014","unstructured":"Desai C, Chen K, Mitra S. Aggregation behavior of nanodiamonds and their functionalized analogs in an aqueous environment. Environ Sci Process Impacts. 2014;16(3):518\u201323. https:\/\/doi.org\/10.1039\/c3em00378g.","journal-title":"Environ Sci Process Impacts"},{"key":"1904_CR64","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1039\/C9NR08984E","volume":"12","author":"SLY Chang","year":"2020","unstructured":"Chang SLY, Reineck P, Williams D, Bryant G, Opletal G, El-Demrdash SA, et al. Dynamic self-assembly of detonation nanodiamond in water. Nanoscale. 2020;12:5363\u20137.","journal-title":"Nanoscale"},{"issue":"8","key":"1904_CR65","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1134\/S1063783412080057","volume":"54","author":"EM Baitinger","year":"2012","unstructured":"Baitinger EM, Belenkov EA, Brzhezinskay MM, Greshnyakovb VA. Specific features of the structure of detonation nanodiamonds from results of electron microscopy investigations. Phys Solid State. 2012;54(8):1715\u201322. https:\/\/doi.org\/10.1134\/S1063783412080057.","journal-title":"Phys Solid State"},{"issue":"1","key":"1904_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/20550324.2019.1710974","volume":"6","author":"J Shojaeiarani","year":"2020","unstructured":"Shojaeiarani J, Bajwa D, Holt G. Sonication amplitude and processing time influence the cellulose nanocrystals morphology and dispersion. Nanocomposites. 2020;6(1):41\u20136. https:\/\/doi.org\/10.1080\/20550324.2019.1710974.","journal-title":"Nanocomposites"},{"issue":"7","key":"1904_CR67","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/nano8070454","volume":"8","author":"RR Retamal Marin","year":"2018","unstructured":"Retamal Marin RR, Babick F, Lindner GG, Wiemann M, Stintz M. Effects of sample preparation on particle size distributions of different types of silica in suspensions. Nanomaterials. 2018;8(7):454. https:\/\/doi.org\/10.3390\/nano8070454.","journal-title":"Nanomaterials."},{"issue":"4","key":"1904_CR68","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/0022-2836(88)90471-8","volume":"201","author":"M Levitt","year":"1988","unstructured":"Levitt M, Perutz MF. Aromatic rings act as hydrogen bond acceptors. J Mol Biol. 1988;201(4):751\u20134.","journal-title":"J Mol Biol"},{"key":"1904_CR69","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.2147\/IJN.S128705","volume":"12","author":"J Li","year":"2017","unstructured":"Li J, Deng J, Yuan J, Fu J, Li X, Tong A, et al. Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury. Int J Nanomedicine. 2017;12:2443\u201356. https:\/\/doi.org\/10.2147\/IJN.S128705.","journal-title":"Int J Nanomedicine"},{"key":"1904_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.diamond.2018.08.005","volume":"89","author":"T Petit","year":"2018","unstructured":"Petit T, Puskar L. FTIR spectroscopy of nanodiamonds: Methods and interpretation. Diam Relat Mater. 2018;89:52\u201366. https:\/\/doi.org\/10.1016\/j.diamond.2018.08.005.","journal-title":"Diam Relat Mater"},{"issue":"2","key":"1904_CR71","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/088307389000500219","volume":"5","author":"O Eeg-Olofsson","year":"1990","unstructured":"Eeg-Olofsson O, Nilsson HL, Tonnby B, Arvidsson J, Grahn PA, Gylje H, et al. Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: A comparison between conventional and slow-release formulations. J Child Neurol. 1990;5(2):159\u201365. https:\/\/doi.org\/10.1177\/088307389000500219.","journal-title":"J Child Neurol"},{"issue":"5\u20138","key":"1904_CR72","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.diamond.2009.01.025","volume":"18","author":"E \u014csawa","year":"2009","unstructured":"\u014csawa E, Ho D, Huang H, Korobov MV, Rozhkova NN. Consequences of strong and diverse electrostatic potential fields on the surface of detonation nanodiamond particles. Diam Relat Mater. 2009;18(5\u20138):904\u20139. https:\/\/doi.org\/10.1016\/j.diamond.2009.01.025.","journal-title":"Diam Relat Mater"},{"issue":"11","key":"1904_CR73","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1021\/nl071521o","volume":"7","author":"H Huang","year":"2007","unstructured":"Huang H, Pierstorff E, Osawa E, Ho D. Active nanodiamond hydrogels for chemotherapeutic delivery. Nano Lett. 2007;7(11):3305\u201314.","journal-title":"Nano Lett"},{"issue":"2","key":"1904_CR74","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0920-1211(93)90021-X","volume":"14","author":"IE Leppik","year":"1993","unstructured":"Leppik IE, Willmore LJ, Homan RW, Fromm G, Oommen KJ, Penry JK, et al. Efficacy and safety of zonisamide: Results of a multicenter study. Epilepsy Res. 1993;14(2):165\u201373. https:\/\/doi.org\/10.1016\/0920-1211(93)90021-X.","journal-title":"Epilepsy Res"},{"issue":"4","key":"1904_CR75","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.3390\/ijms24043390","volume":"24","author":"E Marcello","year":"2023","unstructured":"Marcello E, Chiono V. Biomaterials-enhanced intranasal delivery of drugs as a direct route for brain targeting. Int J Mol Sci. 2023;24(4):3390. https:\/\/doi.org\/10.3390\/ijms24043390.","journal-title":"Int J Mol Sci."},{"key":"1904_CR76","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.3762\/bjoc.10.288","volume":"10","author":"G Jarre","year":"2014","unstructured":"Jarre G, Heyer S, Memmel E, Meinhardt T, Krueger A. Synthesis of nanodiamond derivatives carrying amino functions and quantification by a modified Kaiser test. Beilstein J Org Chem. 2014;10:2729\u201337. https:\/\/doi.org\/10.3762\/bjoc.10.288.","journal-title":"Beilstein J Org Chem"},{"issue":"2","key":"1904_CR77","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s13346-024-01610-0","volume":"15","author":"JR Youssef","year":"2025","unstructured":"Youssef JR, Boraie NA, Ismail FA, Bakr BA, Allam EA, El-Moslemany RM. Brain-targeted lactoferrin-coated lipid nanocapsules for the combined effects of apocynin and lavender essential oil in PTZ-induced seizures. Drug Deliv Transl Res. 2025;15(2):534\u201355. https:\/\/doi.org\/10.1007\/s13346-024-01610-0.","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"1904_CR78","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/pharmaceutics10030116","volume":"10","author":"S Ganger","year":"2018","unstructured":"Ganger S, Schindowski K. Tailoring formulations for intranasal nose-to-brain delivery: A review on architecture, physicochemical characteristics, and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics. 2018;10(3):116. https:\/\/doi.org\/10.3390\/pharmaceutics10030116.","journal-title":"Pharmaceutics."},{"issue":"8","key":"1904_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-013-1834-8","volume":"15","author":"E Perevedentseva","year":"2013","unstructured":"Perevedentseva E, Hong SF, Huang KJ, Chiang IT, Lee CY, Tseng YT, et al. Nanodiamond internalization in cells and the cell uptake mechanism. J Nanopart Res. 2013;15(8):1\u20132. https:\/\/doi.org\/10.1007\/s11051-013-1834-8.","journal-title":"J Nanopart Res."},{"issue":"2","key":"1904_CR80","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"SK Lai","year":"2009","unstructured":"Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61(2):158\u201371. https:\/\/doi.org\/10.1016\/j.addr.2008.11.002.","journal-title":"Adv Drug Deliv Rev"},{"key":"1904_CR81","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcis.2019.04.053","volume":"549","author":"EZ Pi\u00f1a-Salazar","year":"2019","unstructured":"Pi\u00f1a-Salazar EZ, Sakai T, \u014csawa E, Futamura R, Kaneko K. Unusual hygroscopic nature of nanodiamonds in comparison with well-known porous materials. J Colloid Interface Sci. 2019;549:133\u20139. https:\/\/doi.org\/10.1016\/j.jcis.2019.04.053.","journal-title":"J Colloid Interface Sci"},{"issue":"9\u201310","key":"1904_CR82","first-page":"331","volume":"59","author":"P Hal\u00e1sz","year":"2006","unstructured":"Hal\u00e1sz P, Fogarasi A. Temporal lobe epilepsy\u2014State of art review. Ideggyogy Szle. 2006;59(9\u201310):331\u201352.","journal-title":"Ideggyogy Szle"},{"key":"1904_CR83","doi-asserted-by":"publisher","first-page":"107750","DOI":"10.1016\/j.neuropharm.2019.107750","volume":"167","author":"M Barker-Haliski","year":"2020","unstructured":"Barker-Haliski M, White HS. Validated animal models for anti-seizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening. Neuropharmacology. 2020;167:107750. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107750.","journal-title":"Neuropharmacology"},{"issue":"27","key":"1904_CR84","doi-asserted-by":"publisher","first-page":"42021","DOI":"10.1007\/s11042-023-15052-2","volume":"82","author":"AA EinShoka","year":"2023","unstructured":"EinShoka AA, Dessouky MM, El-Sayed A, Hemdan EED. EEG seizure detection: Concepts, techniques, challenges, and future trends. Multimed Tools Appl. 2023;82(27):42021\u201351. https:\/\/doi.org\/10.1007\/s11042-023-15052-2.","journal-title":"Multimed Tools Appl"},{"key":"1904_CR85","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/b978-0-12-823493-8.00021-3","volume":"187","author":"V Frazzini","year":"2022","unstructured":"Frazzini V, Cousyn L, Navarro V. Semiology, EEG, and neuroimaging findings in temporal lobe epilepsies. Handb Clin Neurol. 2022;187:489\u2013518. https:\/\/doi.org\/10.1016\/b978-0-12-823493-8.00021-3.","journal-title":"Handb Clin Neurol"},{"key":"1904_CR86","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jneumeth.2015.03.009","volume":"260","author":"M L\u00e9vesque","year":"2016","unstructured":"L\u00e9vesque M, Avoli M, Bernard C. Animal models of temporal lobe epilepsy following systemic chemoconvulsant administration. J Neurosci Methods. 2016;260:45\u201352. https:\/\/doi.org\/10.1016\/j.jneumeth.2015.03.009.","journal-title":"J Neurosci Methods"},{"issue":"4","key":"1904_CR87","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1017\/s0317167100010441","volume":"37","author":"MM Jan","year":"2010","unstructured":"Jan MM, Sadler M, Rahey SR. Electroencephalographic features of temporal lobe epilepsy. Can J Neurol Sci. 2010;37(4):439\u201348. https:\/\/doi.org\/10.1017\/s0317167100010441.","journal-title":"Can J Neurol Sci"},{"key":"1904_CR88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.seizure.2016.11.029","volume":"44","author":"MM Oto","year":"2017","unstructured":"Oto MM. The misdiagnosis of epilepsy: Appraising risks and managing uncertainty. Seizure. 2017;44:143\u20136. https:\/\/doi.org\/10.1016\/j.seizure.2016.11.029.","journal-title":"Seizure"},{"issue":"4","key":"1904_CR89","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/ane.13616","volume":"146","author":"RK Banote","year":"2022","unstructured":"Banote RK, Akel S, Zelano J. Blood biomarkers in epilepsy. Acta Neurol Scand. 2022;146(4):362\u20138. https:\/\/doi.org\/10.1111\/ane.13616.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"1904_CR90","doi-asserted-by":"publisher","first-page":"13505","DOI":"10.1038\/s41598-020-70560-7","volume":"10","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Li G, Zhao D, Yang P, Shabier T, Tuerxun T. Association between IL-1\u03b2 and recurrence after the first epileptic seizure in ischemic stroke patients. Sci Rep. 2020;10(1):13505. https:\/\/doi.org\/10.1038\/s41598-020-70560-7.","journal-title":"Sci Rep"},{"issue":"1","key":"1904_CR91","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/0028-3886.253616","volume":"67","author":"A Bindra","year":"2019","unstructured":"Bindra A, Kaushal A, Prabhakar H, Chaturvedi A, Chandra PS, Tripathi M, et al. Neuroprotective role of dexmedetomidine in epilepsy surgery: A preliminary study. Neurol India. 2019;67(1):163\u20138. https:\/\/doi.org\/10.4103\/0028-3886.253616.","journal-title":"Neurol India"},{"key":"1904_CR92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2377-12-15","volume":"12","author":"CC Chang","year":"2012","unstructured":"Chang CC, Lui CC, Lee CC, Chen SD, Chang WN, Lu CH, et al. Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy. BMC Neurol. 2012;12:15. https:\/\/doi.org\/10.1186\/1471-2377-12-15.","journal-title":"BMC Neurol"},{"issue":"1","key":"1904_CR93","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/ijms25010502","volume":"25","author":"MA Tikhonova","year":"2023","unstructured":"Tikhonova MA, Shvaikovskaya AA, Zhanaeva SY, Moysak GI, Akopyan AA, Rzaev JA, et al. Concordance between the in vivo content of neurospecific proteins (BDNF, NSE, VILIP-1, S100B) in the hippocampus and blood in patients with epilepsy. Int J Mol Sci. 2023;25(1):502. https:\/\/doi.org\/10.3390\/ijms25010502.","journal-title":"Int J Mol Sci."},{"issue":"10","key":"1904_CR94","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41582-019-0265-2","volume":"15","author":"I Fyfe","year":"2019","unstructured":"Fyfe I. Neurofilament light chain - new potential for prediction and prognosis. Nat Rev Neurol. 2019;15(10):557. https:\/\/doi.org\/10.1038\/s41582-019-0265-2.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1904_CR95","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/epd2.20024","volume":"25","author":"M Ueda","year":"2023","unstructured":"Ueda M, Suzuki M, Hatanaka M, Nakamura T, Hirayama M, Katsuno M. Serum neurofilament light chain in patients with epilepsy and cognitive impairment. Epileptic Disord. 2023;25(2):229\u201336. https:\/\/doi.org\/10.1002\/epd2.20024.","journal-title":"Epileptic Disord"},{"issue":"8","key":"1904_CR96","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/epi.17669","volume":"64","author":"ML Custers","year":"2023","unstructured":"Custers ML, Vande Vyver M, Kaltenb\u00f6ck L, Barb\u00e9 K, Bjerke M, Van Eeckhaut A, et al. Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy? Epilepsia. 2023;64(8):2200\u201311. https:\/\/doi.org\/10.1111\/epi.17669.","journal-title":"Epilepsia"},{"issue":"5","key":"1904_CR97","doi-asserted-by":"publisher","first-page":"749","DOI":"10.5137\/1019-5149.jtn.10738-14.0","volume":"25","author":"G Acar","year":"2015","unstructured":"Acar G, Tanriover G, Acar F, Demir R. Increased expression of matrix metalloproteinase-9 in patients with temporal lobe epilepsy. Turk Neurosurg. 2015;25(5):749\u201356. https:\/\/doi.org\/10.5137\/1019-5149.jtn.10738-14.0.","journal-title":"Turk Neurosurg"},{"issue":"1","key":"1904_CR98","doi-asserted-by":"publisher","first-page":"e138332","DOI":"10.1172\/jci138332","volume":"131","author":"DW Broekaart","year":"2021","unstructured":"Broekaart DW, Bertran A, Jia S, Korotkov A, Senkov O, Bongaarts A, et al. The matrix metalloproteinase inhibitor IPR-179 has anti-seizure and antiepileptogenic effects. J Clin Invest. 2021;131(1):e138332. https:\/\/doi.org\/10.1172\/jci138332.","journal-title":"J Clin Invest."},{"issue":"4","key":"1904_CR99","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s12031-018-1164-5","volume":"66","author":"NA Meguid","year":"2018","unstructured":"Meguid NA, Samir H, Bj\u00f8rklund G, Anwar M, Hashish A, Koura F, et al. Altered S100 calcium-binding protein B and matrix metallopeptidase 9 as biomarkers of mesial temporal lobe epilepsy with hippocampus sclerosis. J Mol Neurosci. 2018;66(4):482\u201391. https:\/\/doi.org\/10.1007\/s12031-018-1164-5.","journal-title":"J Mol Neurosci"},{"key":"1904_CR100","doi-asserted-by":"publisher","unstructured":"Nam S, Cho K-O. The role of epigenetics in the pathophysiology of epilepsy. Neuropsychiatr Dis Epigenetics. 2017:233\u201360. https:\/\/doi.org\/10.1016\/B978-0-12-800226-1.00012-5","DOI":"10.1016\/B978-0-12-800226-1.00012-5"},{"issue":"19","key":"1904_CR101","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.3390\/ijms20194898","volume":"20","author":"C Villa","year":"2019","unstructured":"Villa C, Lavitrano M, Combi R. Long non-coding RNAs and related molecular pathways in the pathogenesis of epilepsy. Int J Mol Sci. 2019;20(19):4898. https:\/\/doi.org\/10.3390\/ijms20194898.","journal-title":"Int J Mol Sci."},{"issue":"4","key":"1904_CR102","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3109\/00207454.2014.994209","volume":"126","author":"G Jiang","year":"2016","unstructured":"Jiang G, Zhou R, He X, Shi Z, Huang M, Yu J, et al. Expression levels of microRNA-199 and hypoxia-inducible factor-1 alpha in brain tissue of patients with intractable epilepsy. Int J Neurosci. 2016;126(4):326\u201334. https:\/\/doi.org\/10.3109\/00207454.2014.994209.","journal-title":"Int J Neurosci"},{"key":"1904_CR103","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.omtn.2018.09.008","volume":"13","author":"C Cava","year":"2018","unstructured":"Cava C, Manna I, Gambardella A, Bertoli G, Castiglioni I. Potential role of miRNAs as theranostic biomarkers of epilepsy. Mol Ther Nucleic Acids. 2018;13:275\u201390. https:\/\/doi.org\/10.1016\/j.omtn.2018.09.008.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1904_CR104","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.2147\/NDT.S142032","volume":"13","author":"T Chen","year":"2017","unstructured":"Chen T, Giri M, Xia Z, Subedi YN, Li Y. Genetic and epigenetic mechanisms of epilepsy: A review. Neuropsychiatr Dis Treat. 2017;13:1841\u201359. https:\/\/doi.org\/10.2147\/NDT.S142032.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1904_CR105","doi-asserted-by":"publisher","unstructured":"Hall AM, Brennan GP, Nguyen TM, Singh-Taylor A, Mun HS, Sargious MJ, et al. The role of Sirt1 in epileptogenesis. eNeuro. 2017;4(1). https:\/\/doi.org\/10.1523\/eneuro.0301-16.2017.","DOI":"10.1523\/eneuro.0301-16.2017"},{"issue":"9","key":"1904_CR106","doi-asserted-by":"publisher","first-page":"16054","DOI":"10.1002\/jcp.28264","volume":"234","author":"T Zhao","year":"2019","unstructured":"Zhao T, Ding Y, Li M, Zhou C, Lin W. Silencing lncRNA PVT1 inhibits activation of astrocytes and increases BDNF expression in hippocampus tissues of rats with epilepsy by downregulating the Wnt signaling pathway. J Cell Physiol. 2019;234(9):16054\u201367. https:\/\/doi.org\/10.1002\/jcp.28264.","journal-title":"J Cell Physiol"},{"key":"1904_CR107","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neuro.2020.05.005","volume":"79","author":"Z Kazmi","year":"2020","unstructured":"Kazmi Z, Zeeshan S, Khan A, Malik S, Shehzad A, Seo EK, et al. Anti-epileptic activity of daidzin in PTZ-induced mice model by targeting oxidative stress and BDNF\/VEGF signaling. Neurotoxicology. 2020;79:150\u201363. https:\/\/doi.org\/10.1016\/j.neuro.2020.05.005.","journal-title":"Neurotoxicology"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01904-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01904-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01904-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:57:00Z","timestamp":1788353820000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01904-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":107,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1904"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01904-x","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"19 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal studies in this work were done after the approval of the October for Modern Sciences and Arts (MSA) University ethics committee (Approval# PT2\/Ec2\/2022PD), which followed the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing financial or non-financial interests to declare.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}